BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33132082)

  • 1. Detection of Copy Number Variants by Short Multiply Aggregated Sequence Homologies.
    Jobanputra V; Andrews P; Felice V; Abhyankar A; Kozon L; Robinson D; London F; Hakker I; Wrzeszczynski K; Ronemus M
    J Mol Diagn; 2020 Dec; 22(12):1476-1481. PubMed ID: 33132082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic yield of the chromosomal microarray analysis in turkish patients with unexplained development delay/ıntellectual disability(ID), autism spectrum disorders and/or multiple congenital anomalies and new clinical findings.
    Akkus N; Cubuk PO
    Mol Biol Rep; 2024 Apr; 51(1):577. PubMed ID: 38664339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Pass Genome Sequencing: Validation and Diagnostic Utility from 409 Clinical Cases of Low-Pass Genome Sequencing for the Detection of Copy Number Variants to Replace Constitutional Microarray.
    Chaubey A; Shenoy S; Mathur A; Ma Z; Valencia CA; Reddy Nallamilli BR; Szekeres E; Stansberry L; Liu R; Hegde MR
    J Mol Diagn; 2020 Jun; 22(6):823-840. PubMed ID: 32344035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMASH, a fragmentation and sequencing method for genomic copy number analysis.
    Wang Z; Andrews P; Kendall J; Ma B; Hakker I; Rodgers L; Ronemus M; Wigler M; Levy D
    Genome Res; 2016 Jun; 26(6):844-51. PubMed ID: 27197213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
    Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
    BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
    Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
    Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
    Shin S; Yu N; Choi JR; Jeong S; Lee KA
    Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India.
    Sharma P; Gupta N; Chowdhury MR; Sapra S; Ghosh M; Gulati S; Kabra M
    Gene; 2016 Sep; 590(1):109-19. PubMed ID: 27291820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
    Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D
    Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical benefit of array-based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay.
    Wayhelova M; Smetana J; Vallova V; Hladilkova E; Filkova H; Hanakova M; Vilemova M; Nikolova P; Gromesova B; Gaillyova R; Kuglik P
    BMC Med Genomics; 2019 Jul; 12(1):111. PubMed ID: 31337399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.
    Cappuccio G; Vitiello F; Casertano A; Fontana P; Genesio R; Bruzzese D; Ginocchio VM; Mormile A; Nitsch L; Andria G; Melis D
    Ital J Pediatr; 2016 Apr; 42():39. PubMed ID: 27072107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent copy number variations as risk factors for autism spectrum disorders: analysis of the clinical implications.
    Oikonomakis V; Kosma K; Mitrakos A; Sofocleous C; Pervanidou P; Syrmou A; Pampanos A; Psoni S; Fryssira H; Kanavakis E; Kitsiou-Tzeli S; Tzetis M
    Clin Genet; 2016 Jun; 89(6):708-18. PubMed ID: 26777411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Yield of Chromosomal Microarray Analysis in a Cohort of Patients with Autism Spectrum Disorders from a Highly Consanguineous Population.
    Al-Mamari W; Al-Saegh A; Al-Kindy A; Bruwer Z; Al-Murshedi F; Al-Thihli K
    J Autism Dev Disord; 2015 Aug; 45(8):2323-8. PubMed ID: 25703031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants.
    Kearney HM; Thorland EC; Brown KK; Quintero-Rivera F; South ST;
    Genet Med; 2011 Jul; 13(7):680-5. PubMed ID: 21681106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Array-CGH analysis in patients with intellectual disability and/or congenital malformations in Brazil.
    Vianna GS; Medeiros PF; Alves AF; Silva TO; Jehee FS
    Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of array comparative genomic hybridization in clinical diagnostics of intellectual disability in children.
    Bartnik M; Wiśniowiecka-Kowalnik B; Nowakowska B; Smyk M; Kędzior M; Sobecka K; Kutkowska-Kaźmierczak A; Klapecki J; Szczałuba K; Castañeda J; Własienko P; Bezniakow N; Obersztyn E; Bocian E
    Dev Period Med; 2014; 18(3):307-17. PubMed ID: 25182394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficient genetic test flow for multiple congenital anomalies and intellectual disability.
    Yokoi T; Enomoto Y; Tsurusaki Y; Harada N; Saito T; Nagai JI; Naruto T; Kurosawa K
    Pediatr Int; 2020 May; 62(5):556-561. PubMed ID: 31955471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability.
    Kim HJ; Park CI; Lim JW; Lee GM; Cho E; Kim HJ
    Yonsei Med J; 2018 May; 59(3):431-437. PubMed ID: 29611406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.